MYD88 and obesity disorder: This is further supported by recent evidence demonstrating that astrocytic deletion of IL‐1 (NLRP3‐dependent cytokine) receptor signaling adaptor MyD88 (myeloid differentiation primary response protein) inhibits obesity pathogenesis in mice [15].